Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

IRWD POWR Grades

• IRWD scores best on the Value dimension, with a Value rank ahead of 98.14% of US stocks.
• The strongest trend for IRWD is in Growth, which has been heading down over the past 179 days.
• IRWD's current lowest rank is in the Momentum metric (where it is better than 12.28% of US stocks).

IRWD Stock Summary

• With a one year PEG ratio of 5.74, Ironwood Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 23.16% of US stocks.
• With a price/earnings ratio of 3.88, Ironwood Pharmaceuticals Inc P/E ratio is greater than that of about only 3.56% of stocks in our set with positive earnings.
• Over the past twelve months, IRWD has reported earnings growth of 67.56%, putting it ahead of 73.3% of US stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Ironwood Pharmaceuticals Inc are PGEN, GKOS, KN, TMDX, and AFIB.
• IRWD's SEC filings can be seen here. And to visit Ironwood Pharmaceuticals Inc's official web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

• In comparison to the median Healthcare stock, IRWD's price/sales ratio is 36.84% higher, now standing at 5.2.
• Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.
• Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.

Below are key valuation metrics over time for IRWD.

IRWD Growth Metrics

Its year over year cash and equivalents growth rate is now at 89.42%.
• Its 3 year revenue growth rate is now at 85.47%.
• Its 3 year net cashflow from operations growth rate is now at -16.06%.

Over the past 34 months, IRWD's revenue has gone up $67,539,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	413.753	261.895	528.448
2021-09-30	413.303	248.84	530.278
2021-06-30	413.024	227.407	508.856
2021-03-31	398.425	198.927	142.757
2020-12-31	389.523	168.836	106.176
2020-09-30	399.144	144.903	110.83

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
• IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
• LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.